ADVANCED DRUG DELIVERY REVIEWS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程药学医学审稿时间:约3个月接收率：约5% sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

各个杂志社对关键词的数目有要求么？

58 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程药学医学审稿时间:约3个月接收率：约5% sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]

2021-12-27 Mia

一般期刊要求关键词有多少个？

55 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程药学医学审稿时间:约3个月接收率：约5% sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]

2019-02-28 ms9497043704145630

很方便啊，以后会常来的。

123 0

[GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程药学医学审稿时间:约3个月接收率：约5% sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]

2018-10-27 nnnuclear

审稿速度:2.0 | 投稿命中率:25.0
经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。

219 0

[GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程药学医学审稿时间:约3个月接收率：约5% sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]

2016-07-07 ms3036779279854874

研究方向：生物工程药学医学审稿时间:约3个月接收率：约5%
sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。

125 0

[GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程药学医学审稿时间:约3个月接收率：约5% sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]

2016-06-10 taddy

审稿速度:3.0 | 投稿命中率:5.0
经验分享：好杂志。发了很多生物工程方面的文章。

377 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务